Aortic arch pathologies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Ageg >=18 years old; 2) Signed the informed consent by himself or the legal representative; 3) Patients diagnosed with thoracoabdominal aortic aneurysm; 4) Unobstructed iliac and femoral artery access; 5) The length of the proximal aneurysm neck of the aortic aneurysm is >= 15mm, and the distal landing zone of the aortic aneurysm is >= 15mm; 6) Morphologically suitable for endovascular repair; 7) The patient has at least a survival expectation of more than 1 year.
Exclusion criteria
Exclusion criteria: 1) The patient is a pregnant or breastfeeding woman; 2) The patient has a history of surgical repair or endovascular treatment of the aorta; 3) The patient had myocardial infarction or stroke within 3 months before enrollment; 4) The patient has connective tissue disease or active systemic infection; 5) The patient has severe coagulation disorder; 6) Not suitable for patients specified by the specifications of this device; 7) The length of the proximal anchoring zone of thoracoabdominal aortic aneurysm is less than 25mm; 8) Patients with contraindications to X-rays; 9) Those who are allergic to stent materials; 10) The patient has renal insufficiency and cannot tolerate contrast media; 11) Patients who are allergic to contrast agents; 12) The patient has mural thrombus near and distal to the aneurysm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative disease progression and stent status; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of major adverse events related to surgery or device;Immediate technical success following surgery; | — |
Countries
China